However, as loss of the glucocorticoid receptor (GR) has been linked to CD (9), and as AIP is known to inhibit the activity of GR (10), if R16H leads to loss of AIP function, increased GR activity would be predicted, which in turn would enhance glucocorticoid feedback inhibition and therefore suppress adenoma formation. The gene discussed is NR3C1; the disease is adenoma.